ClinicalTrials.gov
public full text
Public Domain
Rilonacept in Subjects With Cardiac Sarcoidosis
The primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after 24 weeks of therapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cardiac Sarcoidosis: A Practical Guide for Cardiologists.#1167004
- Cardiac Sarcoidosis Response To Steroids Trial#882400
- Pilot Randomized Trial With Flecainide in ARVC Patients#842635
- Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)#874873
- Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis#992112
Record · ID 887512
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive